JAK2 and myeloproliferative neoplasm: For negative controls we used the K562 CML cell line, which does not express JAK2 Δexon14, in addition to cell samples from 1) a patient with CML; and 2) two patients with MPN who had been confirmed by RT/PCR to be negative for Δexon14 transcripts.